• Search
  • Helpdesk
  • Sales contact
Get your demo

White Paper

ePRO in early phase oncology trials: A revolution on the horizon

Oncology
While the integration of Patient-Reported Outcomes (PROs) into phase IIb and III clinical trials has become increasingly widespread in the 21st century, their inclusion in early-phase studies, namely Phase I...

Gastrointestinal Tract Diseases Research: Moving Towards Patient-Centered Clinical Trials

Gastroenterology
The management of gastrointestinal tract diseases, especially inflammatory bowel disease (IBD), has been transformed over the past few decades. This...

BYOD on the rise

BYOD
Recent and rapid advances in technology have significantly accelerated the digitalization of clinical trials. The Bring Your Own Device (BYOD)...

Strategies to overcome clinical trials complexities

Decentralized trialseCOA
Clinical research has always been complex, but a significant increase in the level of complexity of clinical trials can have...

Breaking barriers in pediatric clinical trials: perspectives from two expert clinicians

Pediatric
Interview with Begoña Nafria, Head of the Patient Engagement in Research Department at SJD Research Foundation in Spain, and Vivienne...

Improving the clinical trial journey with technology and system integration

Interoperability
Over the last two decades, the clinical trial landscape has rapidly evolved towards more decentralization and increased use of advanced...

Innovation and Partnerships: The Biotech Perspective

biotechCardiology
In the ever-evolving landscape of biotechnology, groundbreaking advancements continue to shape the future of healthcare. In this exclusive interview, Estelle...

ePRO data collection: Decision-making for the adoption of a Bring Your Own Device (BYOD) strategy

BYOD
Electronic devices have been systematically provided to participants to report Patient Reported Outcome (PRO) data in clinical trials and electronic...

Decentralized Clinical Trials
Essential tips to avoid common pitfalls

Scientific advice
Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints need to be captured via...

Do we have the right understanding of how patients perceive digital clinical trials?

Patients insights
Interview with Trishna Bharadia, Health Advocate & Patient Engagement Advisor on the 1,133 patients survey results conducted by Kayentis in...

BYOD: When, why and how?

BYOD
What are the main characteristics that make BYOD a strong feature for decentralized trials? What are the key factors to...

eCOA back-up strategies

No longer the “what if” situation: today’s reality and eCOA back-up strategies.How to ensure they are adapted? There have always...

eCOA set-up

Project management
How to anticipate eCOA complexities and ensure a successful launch? Setting up a study with eCOA should be straight forward:...

eCOA challenges of long term studies

OncologyProject management
How to anticipate eCOA complexities in multi-year studies & develop best practice to support sites? Using eCOA solutions can bring...
Follow us on social media
Subscribe to our newsletter
You may also like

ePRO in early phase oncology trials: A revolution on the...

Patient-Reported Outcomes in early-phase oncology clinical trialsA Stepping Stone to...

Answering the Sustainability Call: Digital Health Technologies and eCOA

Kayentis secures Silver Medal in EcoVadis sustainability evaluation with significant...

Engage patients throughout the clinical trial journey

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.